Australia's Optiscan rises after FDA filing for surgery imaging device

Optiscan Imaging

05/10/2026 24:38

** Shares of Optiscan Imaging OIL.AX rise as much as 18.2% to A$0.195, their highest since August 12
** Medical tech firm applies for US regulatory clearance for its InVue precision surgery device
** InVue provides real-time imaging during surgery, helping doctors view tissue at a microscopic level
** About 323,996 shares change hands, 2.1x the stock's 30-day average volume
** Stock up about 90% this year, including the session's gains

(Reporting by Roshan Thomas in Bengaluru)
((Roshan.Thomas@thomsonreuters.com;))